Form 8.3 - Horizon Therapeutics plc

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Horizon Therapeutics plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BQPVQZ61

Date of dealing

1st August 2023

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,310,595

(1.883%)

-

(2) Derivatives (other than options)

511,000

(0.223%)

511,000

(0.223%)

(3) Options and agreements to purchase/sell

1,789,200

(0.782%)

2,242,200

(0.979%)

Total

6,610,795

(2.888%)

2,753,200

(1.203%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD) (Note 5)

Purchase

100

99.54

Purchase

400

99.81

Purchase

918

99.97

Purchase

100

99.51

Sale

29

100.17

Purchase

200

99.91

Purchase

7,153

100.00

Purchase

200

99.67

Purchase

3,959

99.99

Purchase

550

99.85

Purchase

100

99.49

Purchase

200

99.57

Purchase

60

99.31

Purchase

300

99.95

Purchase

100

99.90

Purchase

100

99.88

Purchase

100

99.93

Purchase

300

99.86

Purchase

100

99.56

Purchase

100

99.50

Purchase

200

99.98

Purchase

300

99.68

Purchase

200

99.94

Purchase

600

99.83

Purchase

500

99.87

Purchase

200

99.71

Purchase

100

99.89

Purchase

96

99.74

Purchase

300

99.92

Purchase

800

99.80

Purchase

200

99.79

Purchase

300

99.96

Purchase

293

99.77

Purchase

100

99.75

Purchase

237

99.70

Purchase

234

99.82

Purchase

29

99.69

Purchase

200

99.66

Purchase

100

99.65

Purchase

30

99.97

Purchase

178

99.91

Purchase

33

100.04

Purchase

12

100.00

Purchase

5

99.67

Purchase

15

99.99

Purchase

166

100.07

Purchase

153

99.95

Purchase

340

100.08

Purchase

10

99.76

Purchase

34

99.86

Purchase

12

100.02

Purchase

24

100.10

Purchase

286

100.12

Purchase

17

100.01

Purchase

22

99.94

Purchase

77

99.83

Purchase

8

99.87

Purchase

392

100.11

Purchase

153

100.06

Purchase

3

100.13

Purchase

32

99.79

Purchase

3

99.75

Purchase

85

99.78

Purchase

99

99.82

Sale

2,053

99.69

Purchase

986

99.81

Sale

586

99.81

Purchase

26

99.97

Purchase

302

99.91

Purchase

31

100.04

Purchase

101

100.00

Purchase

1,004

99.52

Purchase

112

99.67

Purchase

6

99.58

Purchase

100

99.85

Purchase

100

100.05

Purchase

236

100.07

Purchase

4

99.49

Purchase

1,040

99.90

Purchase

167

100.08

Purchase

87

99.88

Purchase

250

99.76

Purchase

22

99.93

Purchase

513

99.86

Purchase

204

100.02

Purchase

1,100

100.10

Purchase

117

100.12

Purchase

1

100.01

Purchase

8

99.98

Purchase

8

99.68

Purchase

9

99.94

Purchase

17

100.23

Purchase

25

99.83

Sale

73

99.83

Purchase

315

100.15

Purchase

812

100.09

Purchase

18

100.11

Purchase

419

100.06

Purchase

83

100.21

Purchase

3

99.55

Purchase

8

99.64

Purchase

27

100.03

Purchase

16

100.13

Purchase

199

100.14

Purchase

3

100.16

Purchase

1

99.92

Purchase

4,748

99.80

Purchase

2

99.77

Purchase

235

99.78

Sale

100

99.78

Purchase

98

99.70

Purchase

45

99.82

Purchase

801

99.69

Purchase

1

99.84

Sale

240

100.04

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Call Option

Purchased

200,000

115.00

American

8/18/2023

 

Put Option

Purchased

80,600

100.00

American

8/18/2023

 

Call Option

Purchased

700

110.00

American

1/19/2024

 

Call Option

Selling

17,200

115.00

American

1/19/2024

 

Put Option

Selling

83,100

95.00

American

8/18/2023

 

Put Option

Selling

1,500

60.00

American

12/15/2023

 

Put Option

Selling

16,500

45.00

American

1/19/2024

 

Put Option

Purchased

16,500

65.00

American

1/19/2024

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

2nd August 2023

Contact name

Stephen Glasper

Telephone number

+44 203 398 2166

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making
disclosure:

Millennium International Management LP

Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates:

Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of
relevant
security

Product
description
e.g. call
option

Written or
purchased

Number of
securities to
which option
or derivative
relates

Exercise
price
per unit

(USD)

Type
e.g.
American,
European
etc.

Expiry
date

IE00BQPVQZ61

Put Option

Purchased

300

80.00

American

1/17/2025

IE00BQPVQZ61

Put Option

Purchased

100,300

90.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Purchased

1,200

110.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

1,200

115.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

50,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

29,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

400

110.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

400

110.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

250,000

85.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Purchased

119,400

110.00

American

17/11/2023

IE00BQPVQZ61

Call Option

Purchased

4,500

110.00

American

10/20/2023

IE00BQPVQZ61

Call Option

Purchased

100,000

100.00

American

12/15/2023

IE00BQPVQZ61

Call Option

Written

100,000

110.00

American

12/15/2023

IE00BQPVQZ61

Put Option

Purchased

100,000

85.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

2,800

100.00

American

10/20/2023

IE00BQPVQZ61

Call Option

Purchased

2,800

100.00

American

17/11/2023

IE00BQPVQZ61

Put Option

Written

50,000

85.00

American

15/09/2023

IE00BQPVQZ61

Put Option

Purchased

150,000

85.00

American

17/11/2023

IE00BQPVQZ61

Put Option

Purchased

2,600

90.00

American

17/11/2023

IE00BQPVQZ61

Put Option

Purchased

40,900

100.00

American

17/11/2023

IE00BQPVQZ61

Call Option

Purchased

200

100.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

200

100.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

100,000

70.00

American

17/11/2023

IE00BQPVQZ61

Call Option

Purchased

300

100.00

American

15/09/2023

IE00BQPVQZ61

Put Option

Purchased

300

100.00

American

15/09/2023

IE00BQPVQZ61

Put Option

Written

100,000

60.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Written

16,900

110.00

American

15/09/2023

IE00BQPVQZ61

Call Option

Purchased

535,200

110.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Written

554,700

115.00

American

1/19/2024

IE00BQPVQZ61

Put Option

Purchased

476,900

95.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

546,500

60.00

American

12/15/2023

IE00BQPVQZ61

Put Option

Written

100,000

65.00

American

7/21/2023

IE00BQPVQZ61

Put Option

Purchased

55,000

70.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Written

200,000

105.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

41,500

45.00

American

1/19/2024

IE00BQPVQZ61

Put Option

Written

66,900

100.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

41,500

65.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Purchased

47,500

101.00

American

8/4/2023

IE00BQPVQZ61

Call Option

Purchased

11,400

100.00

American

8/11/2023

IE00BQPVQZ61

Call Option

Purchased

11,400

101.00

American

8/11/2023

IE00BQPVQZ61

Put Option

Purchased

9,600

100.00

American

8/11/2023

IE00BQPVQZ61

Put Option

Purchased

9,600

101.00

American

8/11/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET
Sequence Number: 1150905
Time of Receipt (offset from UTC): 20230802T143706+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.